At the clinical level, anti-NMDAR, LGI1 and mGluR5 autoantibodies were strongly associated with cognitive impairment [33, 34], AD-like phenotypes [35, 36] and profound amnesia [37], respectively. Here, GRM5 is linked to Alzheimer disease.